Early allogeneic transplantation favorably influences the outcome of adult patients suffering from acute myeloid leukemia

Bone Marrow Transplantation

Volumn 19, Issue 9, 1997, Pages 875-881

  Jourdan, E ^a   Maraninchi, D ^a   Reiffers, J ^b   Gluckman, E ^c   Rio, B ^d   Jouet, J P ^b   Michallet, M ^b   Molina, L ^b   Archimbaud, E ^b   Harousseau, J L ^b   Ifrah, N ^b   Attal, M ^b   Guilhot, F ^b   Kuentz, M ^e   Guyotat, D ^b   Pico, J L ^f   Dauriac, C ^b   Legros, M ^b   Dreyfus, F ^g   Bordigoni, P ^b   Leblond, V ^h   Gratecos, N ^b   Varet, B ⁱ   Auzanneau, C ^j   Tilly, H ^b   Vilmer, E ^k   Bardou, V J ^l   Blaise, D ^a,m   more..

^a BMT Units   (France)

^b Hôpital Saint Louis ^*

^c SAINT LOUIS HOSPITAL   (France)

^d HÔTEL DIEU   (France)

^e HENRI MONDOR HOSPITAL   (France)

^f INSTITUT GUSTAVE ROUSSY   (France)

^g Université Paris Descartes   (France)

^h PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

ⁱ HÔPITAL NECKER ENFANTS MALADES   (France)

^j University of Paris Descartes   (France)

^k HÔPITAL ROBERT DEBRÉ   (France)

^l INSTITUT PAOLI CALMETTES   (France)

^m INSERM   (France)

more..

Author keywords

Allogeneic transplant; AML; Outcome

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER SURVIVAL; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; KARYOTYPING; LEUKEMIA REMISSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RELAPSE; SURVIVAL; TREATMENT OUTCOME; WHOLE BODY RADIATION;

EID: 0030966233     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700761     Document Type: Article

References (33)

1. Stone R, Mayer R. Treatment of the newly diagnosed adult with de novo acute myeloid leukemia. Hematol/Oncol Clin North Am 1993; 7: 47-64.
2. Reiffers J, Gaspard MH, Maraninchi D et al. Comparison of allogencic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission: a prospective controlled trial. Br J Haematol 1989; 72: 57-63.
3. Willemze R, Fibbe W, Kluin-Nelemans J et al. Bone marrow transplantation or chemotherapy as post remission treatment of adult acute myelogenous leukemia. Ann Hematol 1991; 62: 59-63.
4. Zittoun RA, Mandelli F, Willemze R et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne del l'Adulto (GIMEMA) Leukemia Cooperative Groups. New Engl J Med 1995; 332: 217-223.
5. Clift R, Buckner CD, Appelbaum F et al. Allogeneic bone marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens. Blood 1990; 76: 1867-1871.
6. Blaise D, Maraninchi D, Archimbaud E et al. Allogenic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse. Blood 1992; 79: 2578-2582.
7. Cassileth P, Lynch E, Hines J et al. Varying intensity of post-remission therapy in acute myeloid leukemia. Blood 1992; 79: 1924-1930.
8. Mayer R, Davis R, Schiffer C et al. Intensive postremission chemotherapy in adults with acute myeloid leukemia. New Engl J Med 1994; 331: 896-903.
9. Sobocinski K, Horowitz M, Rowlings P et al. Bone marrow transplantation 1994: a report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry. J Immunother 1994; 3: 95-102.
10. Jourdan E, Maraninchi D, Reiffers J et al. Allogeneic bone marrow transplantation remains an efficient consolidation for adults with acute myeloid leukemia even when performed very soon after diagnosis (<100 days). Leukemia 1995; 9: 1068-1071.
11. Storb R, Deeg H, Whitehead J et al. Methotrexate and cyclosporine compared with cyclosporine alone prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. New Engl J Med 1986; 314: 729-735.
12. Kaplan E, Meier P. Non parametric estimations for incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
13. Peto R, Peto J. Asymptomatically efficient rank invariant test procedures. J R Stat Soc (A) 1972; 135: 185-198.
14. Cox D. Regression models and life tables. J R Stat Soc (B) 1972; 34: 187-220.
15. Mayer R. Allogeneic transplantation versus intensive chemotherapy in first remission acute leukemia: is there a 'best choice'? J Clin Oncol 1988; 6: 1532-1536.
16. Appelbaum FR, Fisher LD, Thomas ED. Chemotherapy versus marrow transplantation for adults with non lymphocytic leukemia: a five year follow up. Blood 1988; 72: 174-184.
17. Bishop J. Intensified therapy for acute myeloid leukemia. New Engl J Med 1994; 331: 941-942.
18. Hewlett J, Kopecky KJ, Head D et al. A prospective evaluation of the roles of allogeneic marrow transplantation and low-dose monthly maintenance chemotherapy in the treatment of adult acute myelogenous leukemia (AML): a Southwest Oncology Group study. Leukemia 1995; 9: 562-569.
19. Reiffers J, Stoppa AM, Attal M et al. Autologous stem cell transplantation versus chemotherapy for adult patients with acute myeloid leukemia in first remission: the BGMT Group experience. Nouv Rev Fr Hematol 1993; 35: 17-19.
20. Gorin N, Labopin M, Esperou-Bourdeau H, Gluckman E. Comparison of allogeneic and autologous bone marrow transplantation for acute myeloid leukemia (AML) in Europe. An EBMT survey. Blood 1994; 84 (Suppl. 1): 21 1a.
21. Schiller G, Nimer S, Territo M et al. Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia in first remission. J Clin Oncol 1992; 10: 41-46.
22. Meyers J. Prevention and treatment of cytomegalovirus infection after marrow transplantation. Bone Marrow Transplant 1988; 3: 95-104.
23. Meyers D. Fungal infections in bone marrow transplant patients. Semin Oncol 1990; 17: 10-13.
24. Körbling M, Przepiorka M, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995; 85: 1659-1665.
25. Schmitz N, Dreger P, Suttorp M et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by Filgrastim (granulocyte colony stimulating factor). Blood 1995; 85: 1666-1672.
26. Bensinger WI, Weaver CH, Appelbaum FR et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995; 85: 1655-1658.
27. Carella A, Frassoni F, Damasio E et al. Alllogeneic versus autologous marrow transplantation for patients with acute myeloid leukemia in first marrow remission. An update of the Genoa experience with 159 patients. Leukemia 1992; 6 (Suppl. 4): 78-81.
28. Cassileth P, Andersen J, Lazarus H et al. Autologous bone marrow transplant in myeloid leukemia in first remission. J Clin Oncol 1993; 11: 314-319.
29. Ljungmann P, De Witte T, Verdonck I et al. Bone marrow transplantation for acute myeloblastic leukemia: an EBMT leukaemia working party prospective analysis from HLA-typing. Br J Haematol 1993; 84: 61-66.
30. Sullivan KM, Weiden PL, Storb R et al. Influence of acute and chronic graft versus host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 1989; 6: 1720-1728.
31. Nash R, Pepe M, Storb R et al. Acute graft versus host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood 1992; 80: 1838-1845.
32. Fagioli F, Bacigalupo A, Frassoni F et al. Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: the effect of FAB classification and GVHD prophylaxis. Bone Marrow Transplant 1994; 13: 247-252.
33. Clift RA, Appelbaum FR, Thomas ED. Treatment of chronic myeloid leukemia by marrow transplantation. Blood 1993; 82: 1954-1956.